NTMWD 2025

Opinion: Pricing proposal gives patients a fair shake

by | May 30, 2019 | Opinion

Drug company CEOs recently ventured to Capitol Hill to testify before the Senate Finance Committee.

The executives got an earful from lawmakers, who are rightly concerned about drug spending. Senators are under pressure from voters, 80 percent of whom say “taking action to lower prescription drug prices” should be one of Congress’s top priorities this year.

To this end, the Trump administration recently proposed a rule that could save patients billions at the pharmacy. The rule would make it easier for Americans suffering from chronic diseases to afford needed medications. The reform could even drive down national healthcare spending.

The rule targets pharmacy benefit managers. Insurance companies hire these middlemen to administer prescription plans and negotiate with drug companies for discounts. Manufacturers offer discounts in exchange for PBMs agreeing to include drugs on “formularies,” the lists of medications that insurance plans cover.

The discounts secured by PBMs are substantial. Total discounts and rebates offered by drug companies ballooned to $150 billion in 2017. These discounts amount to roughly one-third of a drug’s list price.

If drug companies are offering ever-larger discounts, why do medicines seem to be getting more expensive for patients? It’s because insurers and PBMs keep these discounts to reduce premiums.

The lower premiums are nice, of course. But they provide minimal help to those who rely on medications and face high out-of-pocket costs.

For instance, a drug might have a list price of $300, but the insurer might acquire it for just $150 after rebates.

However, insurers don’t calculate coinsurance based on the negotiated price. If patients face 20-percent coinsurance, they’ll have to pay $60 every time they refill their prescriptions. If patients could pay coinsurance based on the discounted price, they’d pay just $30.

That $30 difference adds up for patients who take multiple drugs to manage their chronic diseases.

The Trump administration’s proposed rule would end this. It would prohibit PBMs from collecting rebates or discounts for medicines sold through Medicaid or Medicare Part D. Discounts and rebates would only be permitted if they were passed to patients at the pharmacy.

The reform would make it easier for America’s sickest patients to afford their medications. That could drive down overall healthcare spending.

Here’s why. Patients struggle to follow their treatment regimens when they face high out-of-pocket costs. When drug copays double, adherence falls by as much as 45 percent.

Non-adherence, a factor in 10 percent of all hospitalizations, costs our healthcare system between $100 billion and $289 billion each year.

Reducing out-of-pocket costs would improve medication adherence, thereby helping prevent needless suffering while saving our country billions.

Right now, the sickest patients pay a disproportionately high share of drug costs. The administration’s proposal would reduce out-of-pocket spending, helping more Americans afford the prescriptions they need to stay healthy.

 

By Kenneth E. Thorpe, professor of health policy at Emory University and chairman of the Partnership to Fight Chronic Disease.

NTMWD 2025

0 Comments

Collin Fall 2025

Related News

A bit wordy

A bit wordy

Columnist John Moore doesn’t recall ever seeing gloves in a glove box. Courtesy John Moore English is a language full of leftovers. It’s like the bottom shelf of the refrigerator. Filled with things we just can’t seem to toss out. The difference of course is that at...

read more
True Grits

True Grits

Columnist John Moore loves grits. Real grits, that is. Photo John Moore Folks who aren’t from the South invariably aren’t familiar with grits. When they come for a visit, they often twist their eyebrows into a John Belushi-type look after they spot them on their...

read more
Double time

Double time

Columnist John Moore is on a mission to save old timepieces. He needs your help. Photo: John Moore My friend runs a precious metals shop, selling mostly gold and silver. I was there to discuss those very things when a pocket watch caught my eye. An Elgin. My buddy...

read more
A lot on the line

A lot on the line

Columnist John Moore keeps an old rotary phone around. Just in case. Photo by John Moore There are many once-common aspects of the telephone that are now gone. Keep in mind that those born in the 1990s likely have never heard a dial tone, dialed a phone, or talked to...

read more
Clutching the past

Clutching the past

Columnist John Moore learned to drive on a stick shift. He still uses a clutch to operate his tractor. Courtesy John Moore One of the necessities of my youth is now one of your best bets to prevent vehicle theft: a stick shift. I watch a lot of YouTube, and...

read more
Polished

Polished

Columnist John Moore still shines his own shoes. As long as he can find the polish to buy. Courtesy John Moore In some cultures, people wash the feet of guests who arrive at their home. At my parents’ house, I didn’t wash the feet of guests, but I did offer to shine...

read more
The chain gang

The chain gang

Columnist John Moore misses the old chain stores, one of which, Gibson’s, still exists in Kerrville, Texas. Courtesy John Moore Online shopping has turned us into couch potatoes who buy more than we ever used to. Adding items to an imaginary cart and clicking, “Buy...

read more
A free gift inside

A free gift inside

Columnist John Moore eats a lot of jelly, but not for the reason you might think. Courtesy John Moore My sister and I would make a beeline for the cereal aisle at the Piggly Wiggly while my mom did the shopping.  Decisions, decisions. Did we want to roll the dice...

read more
Jumping to conclusions

Jumping to conclusions

Columnist John Moore finds himself a little lost with new technology. Sometimes lost a lot. Courtesy John Moore Folks aren’t counting on each other like we were 50 years ago. And technology is the wedge that’s come between us. Our parents didn’t worry about us much...

read more
Subscribe 300x250 - Love